Altevogt B.M., Hanson S.L. and Leshner A.I. (2008) Autism and the environment: challenges and opportunities for research. Pediatrics 121, 1225–1229.
Alvarez-Saavedra M., Saez M.A., Kang D., Zoghbi H.Y. and Young J.I. (2007) Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis. Human Molecular Genetics 16, 2315–2325.
Amaral D.G. (2011) The promise and the pitfalls of autism research: an introductory note for new autism researchers. Brain Research 1380, 3–9.
Antony J.M., Paquin A., Nutt S.L., Kaplan D.R. and Miller F.D. (2011) Endogenous microglia regulate development of embryonic cortical precursor cells. Journal of Neuroscience Research 89, 286–298.
Armstrong D.D. (2005) Neuropathology of Rett syndrome. Journal of Child Neurology 20, 747–753.
Baccarelli A. and Bollati V. (2009) Epigenetics and environmental chemicals. Current Opinion in Pediatrics 21, 243–251.
Ballas N., Lioy D.T., Grunseich C. and Mandel G. (2009) Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nature Neuroscience 12, 311–317.
Barrientos R.M., Frank M.G., Crysdale N.Y., Chapman T.R., Ahrendsen J.T., Day H.E. et al. (2011) Little exercise, big effects: reversing aging and infection-induced memory deficits, and underlying processes. Journal of Neuroscience 31, 11578–11586.
Battista D., Ferrari C.C., Gage F.H. and Pitossi F.J. (2006) Neurogenic niche modulation by activated microglia: transforming growth factor beta increases neurogenesis in the adult dentate gyrus. European Journal of Neuroscience 23, 83–93.
Bauman M. and Kemper T.L. (1985) Histoanatomic observations of the brain in early infantile autism. Neurology 35, 866–874.
Belichenko N.P., Belichenko P.V. and Mobley W.C. (2009) Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation. Neurobiology of Disease 34, 71–77.
Ben Achour S. and Pascual O. (2010) Glia: the many ways to modulate synaptic plasticity. Neurochemistry International 57, 440–445.
Bessis A., Bechade C., Bernard D. and Roumier A. (2007) Microglial control of neuronal death and synaptic properties. Glia 55, 233–238.
Betancur C., Sakurai T. and Buxbaum J.D. (2009) The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders. Trends in Neurosciences 32, 402–412.
Blinzinger K. and Kreutzberg G. (1968) Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Zeitschrift fur Zellforschung und Mikroskopische Anatomie 85, 145–157.
Block M.L., Zecca L. and Hong J.S. (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Reviews. Neuroscience 8, 57–69.
Borrelli E., Nestler E.J., Allis C.D. and Sassone-Corsi P. (2008) Decoding the epigenetic language of neuronal plasticity. Neuron 60, 961–974.
Braunschweig D., Simcox T., Samaco R.C. and Lasalle J.M. (2004) X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2−/+ mouse brain. Human Molecular Genetics 13, 1275–1286.
Centonze D., Muzio L., Rossi S., Cavasinni F., De Chiara V., Bergami A. et al. (2009) Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. Journal of Neuroscience 29, 3442–3452.
Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T., Qin J. et al. (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224–1229.
Chahrour M. and Zoghbi H.Y. (2007) The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422–437.
Chamak B., Dobbertin A. and Mallat M. (1995) Immunohistochemical detection of thrombospondin in microglia in the developing rat brain. Neuroscience 69, 177–187.
Charleston J.S., Body R.L., Mottet N.K., Vahter M.E. and Burbacher T.M. (1995) Autometallographic determination of inorganic mercury distribution in the cortex of the calcarine sulcus of the monkey Macaca fascicularis following long-term subclinical exposure to methylmercury and mercuric chloride. Toxicology and Applied Pharmacology 132, 325–333.
Chauhan A., Gu F., Essa M.M., Wegiel J., Kaur K., Brown W.T. et al. (2011) Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. Journal of Neurochemistry 117, 209–220.
Chez M.G., Dowling T., Patel P.B., Khanna P. and Kominsky M. (2007) Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatric Neurology 36, 361–365.
Choi S.H., Veeraraghavalu K., Lazarov O., Marler S., Ransohoff R.M., Ramirez J.M. et al. (2008) Non-cell-autonomous effects of presenilin 1 variants on enrichment-mediated hippocampal progenitor cell proliferation and differentiation. Neuron 59, 568–580.
Christopherson K.S., Ullian E.M., Stokes C.C., Mullowney C.E., Hell J.W., Agah A. et al. (2005) Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120, 421–433.
Coker S.B. and Melnyk A.R. (1991) Rett syndrome and mitochondrial enzyme deficiencies. Journal of Child Neurology 6, 164–166.
Colton C.A. (2009) Heterogeneity of microglial activation in the innate immune response in the brain. Journal of Neuroimmune Pharmacology 4, 399–418.
Colton C.A. and Wilcock D.M. (2010) Assessing activation states in microglia. CNS & Neurological Disorders Drug Targets 9, 174–191.
Connolly A.M., Chez M., Streif E.M., Keeling R.M., Golumbek P.T., Kwon J.M. et al. (2006) Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau–Kleffner syndrome, and epilepsy. Biological Psychiatry 59, 354–363.
Cornford M.E., Philippart M., Jacobs B., Scheibel A.B. and Vinters H.V. (1994) Neuropathology of Rett syndrome: case report with neuronal and mitochondrial abnormalities in the brain. Journal of Child Neurology 9, 424–431.
Courchesne E., Karns C.M., Davis H.R., Ziccardi R., Carper R.A., Tigue Z.D. et al. (2001) Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 57, 245–254.
Courchesne E., Pierce K., Schumann C.M., Redcay E., Buckwalter J.A., Kennedy D.P. et al. (2007) Mapping early brain development in autism. Neuron 56, 399–413.
Dalmau I., Finsen B., Zimmer J., Gonzalez B. and Castellano B. (1998) Development of microglia in the postnatal rat hippocampus. Hippocampus 8, 458–474.
Dalmau I., Vela J.M., Gonzalez B., Finsen B. and Castellano B. (2003) Dynamics of microglia in the developing rat brain. Journal of Comparative Neurology 458, 144–157.
Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S. et al. (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nature Neuroscience 8, 752–758.
De Felice C., Ciccoli L., Leoncini S., Signorini C., Rossi M., Vannuccini L. et al. (2009) Systemic oxidative stress in classic Rett syndrome. Free Radical Biology and Medicine 47, 440–448.
Dementieva Y.A., Vance D.D., Donnelly S.L., Elston L.A., Wolpert C.M., Ravan S.A. et al. (2005) Accelerated head growth in early development of individuals with autism. Pediatric Neurology 32, 102–108.
Dotti M.T., Manneschi L., Malandrini A., De Stefano N., Caznerale F. and Federico A. (1993) Mitochondrial dysfunction in Rett syndrome. An ultrastructural and biochemical study. Brain & Development 15, 103–106.
Ekdahl C.T., Kokaia Z. and Lindvall O. (2009) Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 158, 1021–1029.
Eter N., Engel D.R., Meyer L., Helb H.M., Roth F., Maurer J. et al. (2008) In vivo visualization of dendritic cells, macrophages, and microglial cells responding to laser-induced damage in the fundus of the eye. Investigative Ophthalmology and Visual Science 49, 3649–3658.
Faraco G., Pittelli M., Cavone L., Fossati S., Porcu M., Mascagni P. et al. (2009) Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo. Neurobiology of Disease 36, 269–279.
Forman M.S., Lal D., Zhang B., Dabir D.V., Swanson E., Lee V.M. et al. (2005) Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. Journal of Neuroscience 25, 3539–3550.
Frye R.E. and Rossignol D.A. (2011) Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatric Research 69, 41R–47R.
Garg T.K. and Chang J.Y. (2006) Methylmercury causes oxidative stress and cytotoxicity in microglia: attenuation by 15-deoxy-delta 12, 14-prostaglandin J2. Journal of Neuroimmunology 171, 17–28.
Geschwind D.H. (2008) Autism: many genes, common pathways? Cell 135, 391–395.
Geschwind D.H. (2011) Genetics of autism spectrum disorders. Trends in Cognitive Sciences 15, 409–416.
Giacometti E., Luikenhuis S., Beard C. and Jaenisch R. (2007) Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proceedings of the National Academy of Sciences of the U.S.A. 104, 1931–1936.
Gibbons H.M., Smith A.M., Teoh H.H., Bergin P.M., Mee E.W., Faull R.L. et al. (2011) Valproic acid induces microglial dysfunction, not apoptosis, in human glial cultures. Neurobiology of Disease 41, 96–103.
Gibson J.H., Slobedman B., Harikrishnan K.N., Williamson S.L., Minchenko D., El-Osta A. et al. (2010) Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain. BMC Neuroscience 11, 53.
Gilman S.R., Iossifov I., Levy D., Ronemus M., Wigler M. and Vitkup D. (2011) Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70, 898–907.
Giulivi C., Zhang Y.F., Omanska-Klusek A., Ross-Inta C., Wong S., Hertz-Picciotto I. et al. (2010) Mitochondrial dysfunction in autism. Journal of the American Medical Association 304, 2389–2396.
Goines P., Haapanen L., Boyce R., Duncanson P., Braunschweig D., Delwiche L. et al. (2011) Autoantibodies to cerebellum in children with autism associate with behavior. Brain, Behavior, and Immunity 25, 514–523.
Graeber M.B. (2010) Changing face of microglia. Science 330, 783–788.
Greco C.M., Navarro C.S., Hunsaker M.R., Maezawa I., Shuler J.F., Tassone F. et al. (2011) Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome. Molecular Autism 2, 2.
Gupta S., Aggarwal S., Rashanravan B. and Lee T. (1998) Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. Journal Neuroimmunology 85, 106–109.
Guy J., Gan J., Selfridge J., Cobb S. and Bird A. (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143–1147.
Guy J., Hendrich B., Holmes M., Martin J.E. and Bird A. (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nature Genetics 27, 322–326.
Hagerman R., Hoem G. and Hagerman P. (2010) Fragile X and autism: intertwined at the molecular level leading to targeted treatments. Molecular Autism 1, 12.
Hallmayer J., Cleveland S., Torres A., Phillips J., Cohen B., Torigoe T. et al. (2011) Genetic heritability and shared environmental factors among twin pairs with autism. Archives of General Psychiatry 68, 1095–1102.
Hamberger A., Gillberg C., Palm A. and Hagberg B. (1992) Elevated CSF glutamate in Rett syndrome. Neuropediatrics 23, 212–213.
Heilstedt H.A., Shahbazian M.D. and Lee B. (2002) Infantile hypotonia as a presentation of Rett syndrome. American Journal of Medical Genetics 111, 238–242.
Hickman S.E., Allison E.K. and El Khoury J. (2008) Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. Journal of Neuroscience 28, 8354–8360.
Horska A., Farage L., Bibat G., Nagae L.M., Kaufmann W.E., Barker P.B. et al. (2009) Brain metabolism in Rett syndrome: age, clinical, and genotype correlations. Annals of Neurology 65, 90–97.
Hoshino Y., Kaneko M., Yashima Y., Kumashiro H., Volkmar F.R. and Cohen D.J. (1987) Clinical features of autistic children with setback course in their infancy. Japanese Journal of Psychiatry and Neurology 41, 237–245.
Jayakumar A.R., Rama Rao K.V., Schousboe A. and Norenberg M.D. (2004) Glutamine-induced free radical production in cultured astrocytes. Glia 46, 296–301.
Jellinger K.A. (2003) Rett syndrome – an update. Journal of Neural Transmission 110, 681–701.
Johnstone R.W. (2002) Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nature Reviews. Drug Discovery 1, 287–299.
Jones P.L., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N. et al. (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genetics 19, 187–191.
Jugloff D.G., Vandamme K., Logan R., Visanji N.P., Brotchie J.M. and Eubanks J.H. (2008) Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice. Human Molecular Genetics 17, 1386–1396.
Jyonouchi H., Sun S. and Le H. (2001) Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. Journal Neuroimmunology 120, 170–179.
Kanner L. and Eisenberg L. (1958) Child psychiatry, mental deficiency. American Journal of Psychiatry 114, 609–615.
Kemper T.L. and Bauman M. (1998) Neuropathology of infantile autism. Journal of Neuropathology and Experimental Neurology 57, 645–652.
Kern J.K. and Jones A.M. (2006) Evidence of toxicity, oxidative stress, and neuronal insult in autism. Journal of Toxicology and Environmental Health. Part B, Critical Reviews 9, 485–499.
Kettenmann H., Hanisch U.K., Noda M. and Verkhratsky A. (2011) Physiology of microglia. Physiological Reviews 91, 461–553.
Kim J.V., Jiang N., Tadokoro C.E., Liu L., Ransohoff R.M., Lafaille J.J. et al. (2010) Two-photon laser scanning microscopy imaging of intact spinal cord and cerebral cortex reveals requirement for CXCR6 and neuroinflammation in immune cell infiltration of cortical injury sites. Journal of Immunological Methods 352, 89–100.
Kishi N. and Macklis J.D. (2004) MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Molecular and Cellular Neurosciences 27, 306–321.
Kriaucionis S., Paterson A., Curtis J., Guy J., Macleod N. and Bird A. (2006) Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Molecular and Cellular Biology 26, 5033–5042.
Kurita H. (1985) Infantile autism with speech loss before the age of thirty months. Journal of the American Academy of Child Psychiatry 24, 191–196.
Landrigan P.J. (2010) What causes autism? Exploring the environmental contribution. Current Opinion in Pediatrics 22, 219–225.
Lappalainen R. and Riikonen R.S. (1996) High levels of cerebrospinal fluid glutamate in Rett syndrome. Pediatric Neurology 15, 213–216.
Lasalle J.M. (2011) A genomic point-of-view on environmental factors influencing the human brain methylome. Epigenetics 6, 862–869.
Lasalle J.M. and Yasui D.H. (2009) Evolving role of MeCP2 in Rett syndrome and autism. Epigenomics 1, 119–130.
Leblanc J.J. and Fagiolini M. (2011) Autism: a “critical period” disorder? Neural Plasticity 2011, 921680.
Levitt P. and Campbell D.B. (2009) The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. Journal of Clinical Investigation 119, 747–754.
Lioy D.T., Garg S.K., Monaghan C.E., Raber J., Foust K.D., Kaspar B.K. et al. (2011) A role for glia in the progression of Rett's syndrome. Nature 475, 497–500.
Lokensgard J.R., Hu S., Van Fenema E.M., Sheng W.S. and Peterson P.K. (2000) Effect of thalidomide on chemokine production by human microglia. Journal of Infectious Diseases 182, 983–987.
Luikenhuis S., Giacometti E., Beard C.F. and Jaenisch R. (2004) Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proceedings of the National Academy of Sciences of the U.S.A. 101, 6033–6038.
Luo Y., Shan G., Guo W., Smrt R.D., Johnson E.B., Li X. et al. (2010) Fragile x mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells. PLoS Genetics 6, .
Maezawa I. and Jin L.W. (2010) Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. Journal of Neuroscience 30, 5346–5356.
Maezawa I., Swanberg S., Harvey D., Lasalle J.M. and Jin L.W. (2009) Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. Journal of Neuroscience 29, 5051–5061.
Marin-Teva J.L., Dusart I., Colin C., Gervais A., Van Rooijen N. and Mallat M. (2004) Microglia promote the death of developing Purkinje cells. Neuron 41, 535–547.
McFarlane H.G., Kusek G.K., Yang M., Phoenix J.L., Bolivar V.J. and Crawley J.N. (2008) Autism-like behavioral phenotypes in BTBR T + tf/J mice. Genes, Brain and Behavior 7, 152–163.
McPherson C.A., Kraft A.D. and Harry G.J. (2011) Injury-induced neurogenesis: consideration of resident microglia as supportive of neural progenitor cells. Neurotoxicity Research 19, 341–352.
Minshew N.J. and Keller T.A. (2010) The nature of brain dysfunction in autism: functional brain imaging studies. Current Opinion in Neurology 23, 124–130.
Miyazaki K., Narita N., Sakuta R., Miyahara T., Naruse H., Okado N. et al. (2004) Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain & Development 26, 292–295.
Monnet-Tschudi F. (1998) Induction of apoptosis by mercury compounds depends on maturation and is not associated with microglial activation. Journal of Neuroscience Research 53, 361–367.
Moore S.J., Turnpenny P., Quinn A., Glover S., Lloyd D.J., Montgomery T. et al. (2000) A clinical study of 57 children with fetal anticonvulsant syndromes. Journal of Medical Genetics 37, 489–497.
Moreno J.A., Streifel K.M., Sullivan K.A., Legare M.E. and Tjalkens R.B. (2009) Developmental exposure to manganese increases adult susceptibility to inflammatory activation of glia and neuronal protein nitration. Toxicological Sciences 112, 405–415.
Morgan J.T., Chana G., Pardo C.A., Achim C., Semendeferi K., Buckwalter J. et al. (2010) Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biological Psychiatry 68, 368–376.
Mullaney B.C., Johnston M.V. and Blue M.E. (2004) Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience 123, 939–949.
Mutter J., Naumann J., Schneider R., Walach H. and Haley B. (2005) Mercury and autism: accelerating evidence? Neuroendocrinology Letters 26, 439–446.
Nagarajan R.P., Hogart A.R., Gwye Y., Martin M.R. and Lasalle J.M. (2006) Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics 1, e1–e11.
Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N. et al. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386–389.
Ni M., Li X., Yin Z., Jiang H., Sidoryk-Wegrzynowicz M., Milatovic D. et al. (2010) Methylmercury induces acute oxidative stress, altering Nrf2 protein level in primary microglial cells. Toxicological Sciences 116, 590–603.
Nimmerjahn A., Kirchhoff F. and Helmchen F. (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314–1318.
Onishchenko N., Karpova N., Sabri F., Castren E. and Ceccatelli S. (2008) Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury. Journal of Neurochemistry 106, 1378–1387.
Onore C., Careaga M. and Ashwood P. (2012) The role of immune dysfunction in the pathophysiology of autism. Brain, Behavior, and Immunity 26, 383–392.
Ott P., Clemmesen O. and Larsen F.S. (2005) Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis. Neurochemistry International 47, 13–18.
Paolicelli R.C., Bolasco G., Pagani F., Maggi L., Scianni M., Panzanelli P. et al. (2011) Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456–1458.
Pardo C.A., Vargas D.L. and Zimmerman A.W. (2005) Immunity, neuroglia and neuroinflammation in autism. International Review of Psychiatry 17, 485–495.
Perry E.K., Lee M.L., Martin-Ruiz C.M., Court J.A., Volsen S.G., Merrit J. et al. (2001) Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. American Journal of Psychiatry 158, 1058–1066.
Pessah I.N., Seegal R.F., Lein P.J., Lasalle J., Yee B.K., Van De Water J. et al. (2008) Immunologic and neurodevelopmental susceptibilities of autism. Neurotoxicology 29, 532–545.
Philippart M. (1986) Clinical recognition of Rett syndrome. American Journal of Medical Genetics. Supplement 1, 111–118.
Rama Rao K.V., Jayakumar A.R. and Norenberg M.D. (2003) Induction of the mitochondrial permeability transition in cultured astrocytes by glutamine. Neurochemistry International 43, 517–523.
Ramocki M.B., Peters S.U., Tavyev Y.J., Zhang F., Carvalho C.M., Schaaf C.P. et al. (2009) Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Annals of Neurology 66, 771–782.
Ransohoff R.M. and Perry V.H. (2009) Microglial physiology: unique stimuli, specialized responses. Annual Review of Immunology 27, 119–145.
Rasalam A.D., Hailey H., Williams J.H., Moore S.J., Turnpenny P.D., Lloyd D.J. et al. (2005) Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Developmental Medicine and Child Neurology 47, 551–555.
Rice C. (2009) Prevalence of autism spectrum disorders – Autism and Developmental Disabilities Monitoring Network, United States, (2006) MMWR. Surveillance Summaries. 2009/12/22 ed. Atlanta, GA: Center for Disease Control and Prevention.
Ruch A., Kurczynski T.W. and Velasco M.E. (1989) Mitochondrial alterations in Rett syndrome. Pediatric Neurology 5, 320–323.
Russell J.C., Blue M.E., Johnston M.V., Naidu S. and Hossain M.A. (2007) Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxia. Neuroscience 150, 563–574.
Schmid R.S., Tsujimoto N., Qu Q., Lei H., Li E., Chen T. et al. (2008) A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome. Neuroreport 19, 393–398.
Shahbazian M.D., Antalffy B., Armstrong D.L. and Zoghbi H.Y. (2002) Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Human Molecular Genetics 11, 115–124.
Sheikh A.M., Malik M., Wen G., Chauhan A., Chauhan V., Gong C.X., et al. (2010) BDNF-Akt-Bcl2 antiapoptotic signaling pathway is compromised in the brain of autistic subjects. Journal of Neuroscience Research 88, 2641–2647.
Shepherd G.M. and Katz D.M. (2011) Synaptic microcircuit dysfunction in genetic models of neurodevelopmental disorders: focus on Mecp2 and Met. Current Opinion in Neurobiology 21, 827–833.
Shin R.W., Iwaki T., Kitamoto T. and Tateishi J. (1991) Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Laboratory Investigation 64, 693–702.
Sierra C., Vilaseca M.A., Brandi N., Artuch R., Mira A., Nieto M. et al. (2001) Oxidative stress in Rett syndrome. Brain & Development 23 (Suppl. 1), S236–S239.
Stence N., Waite M. and Dailey M.E. (2001) Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices. Glia 33, 256–266.
Stephenson D.T., O'Neill S.M., Narayan S., Tiwari A., Arnold E., Samaroo H.D. et al. (2011) Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis. Molecular Autism 2, 7.
Stromland K., Nordin V., Miller M., Akerstrom B. and Gillberg C. (1994) Autism in thalidomide embryopathy: a population study. Developmental Medicine and Child Neurology 36, 351–356.
Sudhof T.C. (2008) Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903–911.
Svoboda N. and Kerschbaum H.H. (2009) L-Glutamine-induced apoptosis in microglia is mediated by mitochondrial dysfunction. European Journal of Neuroscience 30, 196–206.
Sweeten T.L., Posey D.J., Shankar S. and McDougle C.J. (2004) High nitric oxide production in autistic disorder: a possible role for interferon-gamma. Biological Psychiatry 55, 434–437.
Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R. et al. (2006) Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. Journal of Biological Chemistry 281, 21362–21368.
Trapp B.D., Wujek J.R., Criste G.A., Jalabi W., Yin X., Kidd G.J. et al. (2007) Evidence for synaptic stripping by cortical microglia. Glia 55, 360–368.
Tremblay M.E., Lowery R.L. and Majewska A.K. (2010) Microglial interactions with synapses are modulated by visual experience. PLoS Biology 8, .
Van Kooten I.A., Palmen S.J., Von Cappeln P., Steinbusch H.W., Korr H., Heinsen H. et al. (2008) Neurons in the fusiform gyrus are fewer and smaller in autism. Brain 131, 987–999.
Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W. and Pardo C.A. (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology 57, 67–81.
Villafuerte S. (2011) Suggestive evidence on the genetic link between mitochondria dysfunction and autism. Acta Psychiatrica Scandinavica 123, .
Volkmar F.R. and Cohen D.J. (1989) Disintegrative disorder or “late onset” autism. Journal of Child Psychology and Psychiatry 30, 717–724.
Wakai S., Kameda K., Ishikawa Y., Miyamoto S., Nagaoka M., Okabe M. et al. (1990) Rett syndrome: findings suggesting axonopathy and mitochondrial abnormalities. Pediatric Neurology 6, 339–343.
Wake H., Moorhouse A.J., Jinno S., Kohsaka S. and Nabekura J. (2009) Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. Journal of Neuroscience 29, 3974–3980.
Wallace D.C. and Fan W. (2010) Energetics, epigenetics, mitochondrial genetics. Mitochondrion 10, 12–31.
Wegiel J., Kuchna I., Nowicki K., Imaki H., Marchi E., Ma S.Y. et al. (2010) The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathologica 119, 755–770.
Wills S., Cabanlit M., Bennett J., Ashwood P., Amaral D.G. and Van De Water J. (2009) Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain, Behavior, and Immunity 23, 64–74.
Woodward G. (2001) Autism and Parkinson's disease. Medical Hypotheses 56, 246–249.
Xu J., Xiao N. and Xia J. (2010) Thrombospondin 1 accelerates synaptogenesis in hippocampal neurons through neuroligin 1. Nature Neuroscience 13, 22–24.
Yasui D.H., Peddada S., Bieda M.C., Vallero R.O., Hogart A., Nagarajan R.P. et al. (2007) Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proceedings of the National Academy of Sciences of the U.S.A. 104, 19416–19421.
Yeargin-Allsopp M., Rice C., Karapurkar T., Doernberg N., Boyle C. and Murphy C. (2003) Prevalence of autism in a US metropolitan area. Journal of the American Medical Association 289, 49–55.
Yirmiya R. and Goshen I. (2011) Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain, Behavior, and Immunity 25, 181–213.
Zhang B., West E.J., Van K.C., Gurkoff G.G., Zhou J., Zhang X.M. et al. (2008) HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats. Brain Research 1226, 181–191.
Zhao J., Lopez A.L., Erichsen D., Herek S., Cotter R.L., Curthoys N.P. et al. (2004) Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages: linkage to HIV-1 associated dementia. Journal of Neurochemistry 88, 169–180.
Ziv Y., Ron N., Butovsky O., Landa G., Sudai E., Greenberg N. et al. (2006) Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nature Neuroscience 9, 268–275.
Zoghbi H.Y. (2003) Postnatal neurodevelopmental disorders: meeting at the synapse? Science 302, 826–830.
Zoghbi H.Y. (2009) Rett syndrome: what do we know for sure? Nature Neuroscience 12, 239–240.